BORA PHARMACEUTICAL LABORATORIES INC

Company Type: Manufacturer

Corporate Profile:

Bora Pharmaceutical Laboratories Inc. is a leading contract development and manufacturing organization (CDMO) based in Taiwan. The company specializes in providing high-quality pharmaceutical manufacturing services, including oral solid dosage forms, liquids, and semi-solids. With state-of-the-art facilities that adhere to international regulatory standards such as US FDA, EU EMA, and TFDA, Bora Pharmaceutical serves global pharmaceutical companies by offering end-to-end solutions from formulation development and clinical trial manufacturing to large-scale commercial production and packaging. The company is committed to operational excellence, rigorous quality control, and expanding its global footprint to support the development of innovative and generic medicines.

BORA Pharmaceutical Laboratories Inc. is a leading Contract Development and Manufacturing Organization (CDMO) based in Taiwan. As a CDMO, BORA manufactures a wide range of pharmaceutical products for its global clients, rather than selling its own branded products directly to consumers.

The types of pharmaceutical products BORA is capable of manufacturing for its clients include:

Oral Solid Dosage Forms: Tablets (such as coated, uncoated, chewable, effervescent tablets), Capsules (including hard gelatin capsules and softgels), Powders, and Granules.

Oral Liquid Dosage Forms: Syrups, Suspensions, and Solutions.

Semi-Solid Dosage Forms: Creams, Ointments, and Gels.

Sterile Injectable Products: Including products filled into vials and pre-filled syringes.

Active Pharmaceutical Ingredients (APIs): Primarily through its specialized subsidiaries and facilities.

They also produce various Over-the-Counter (OTC) drugs and Prescription drugs across different therapeutic areas, including certain controlled substances, all under the brand names of their respective client companies.